- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Trump May Include HIV Plan in Speech; Judge Tosses ACA Suit; CF Treatment Gaps
While President Trump's State of the Union address is not finalized, he may plan to unveil a promise to end HIV transmission in America by 2030; a federal judge dismissed a lawsuit brought by Maryland that claimed the Trump administration is failing to enforce the Affordable Care Act; new cystic fibrosis (CF) treatments targeting the genetic mutations that cause the disease help about 90% of patients, meaning that 10% are still waiting for a cutting-edge therapy.
Plan to Eliminate HIV in US Might Be in Trump's State of the Union Speech
While President Trump's State of the Union address is not finalized, officials told Politico that he plans to unveil a promise to end HIV transmission in America by 2030. The plan, which has been championed by health officials, including HHS Secretary Alex Azar and Robert Redfield, head of the CDC, would target US communities with the most HIV infections.
Judge Dismisses Maryland ACA Lawsuit Against Trump Administration
A federal judge dismissed a lawsuit brought by Maryland that claimed the Trump administration is failing to enforce the Affordable Care Act (ACA), The Washington Post reported. The Maryland suit argued that the administration’s enthusiasm for sabotaging the law was evident when the United States refused to defend its constitutionality in a Texas ACA case against HHS. Late last year, a federal judge in Texas ruled that the entire law is unconstitutional. The judge who dismissed the Maryland lawsuit said that the state could revive it if it brings more proof that the administration is failing to stand by the law.
Ten Percent of Patients With CF Patients Still Hoping For Targeted Treatment
New cystic fibrosis (CF) treatments targeting the genetic mutations that cause the disease help about 90% of patients, meaning that 10% are still waiting for a cutting-edge therapy, STAT News reported. The difference has meant a gap in treatment for the illness, which is caused by more than 1500 mutations in the CFTR gene.
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
